These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6184353)

  • 1. Suppressor factors and their potential for immunotherapy, and chemical influences on interferons.
    Gainer JH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1107-10. PubMed ID: 6184353
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of interferons produced by different cell populations.
    Nossik NN; Bopegamage SA; Yershov FI
    Acta Microbiol Hung; 1988; 35(4):397-403. PubMed ID: 2469281
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymosin peptides and lymphokines do not directly stimulate adrenal corticosteroid production in vitro.
    Vahouny GV; Kyeyune-Nyombi E; McGillis JP; Tare NS; Huang KY; Tombes R; Goldstein AL; Hall NR
    J Immunol; 1983 Feb; 130(2):791-4. PubMed ID: 6184406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains.
    Giron DJ; Agostini HJ; Thomas DC
    J Interferon Res; 1988 Dec; 8(6):745-53. PubMed ID: 2466089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo release of lymphokines in different strains of mice.
    Neta R; Salvin SB
    Cell Immunol; 1980 Apr; 51(1):173-8. PubMed ID: 6153932
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble factors in tolerance and contact sensitivity to DNFB in mice. V. Genetic requirements for stimulating suppressor factor production in vitro.
    Moorhead JW
    J Immunol; 1982 Nov; 129(5):1837-42. PubMed ID: 7119435
    [No Abstract]   [Full Text] [Related]  

  • 7. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
    Carter WA; O'Malley J
    Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of interferon in experimental viral diseases].
    German A; Quero AM
    Bull Acad Natl Med; 1983 Feb; 167(2):163-9. PubMed ID: 6196097
    [No Abstract]   [Full Text] [Related]  

  • 9. Does physiological interferon play a role in Mengo virus infection of mice?
    Błach-Olszewska Z; Veckenstedt A; Zaczyńska E
    Acta Virol; 1993 Feb; 37(1):68-72. PubMed ID: 7692712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages.
    Aune TM; Pierce CW
    J Immunol; 1981 Nov; 127(5):1828-33. PubMed ID: 7197699
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral activity of a thymic factor in experimental viral infections. I. Thymic hormonal effect on survival, interferon production and NK cell activity in Mengo virus-infected mice.
    Klein AS; Fixler R; Shoham J
    J Immunol; 1984 Jun; 132(6):3159-63. PubMed ID: 6202776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of immune responses by I-J gene products. IV. Distinct suppressor factors derived from "nonsuppressor" A strain mice.
    Lei HY; Waltenbaugh C
    J Immunol; 1984 Oct; 133(4):1723-9. PubMed ID: 6206133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune responses by I-J gene products. III. GT-specific suppressor factor is composed of separate I-J and idiotype-bearing chains.
    Lei HY; Ju ST; Dorf ME; Waltenbaugh C
    J Immunol; 1983 Mar; 130(3):1274-9. PubMed ID: 6185576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy: the old and the new.
    Oldham RK; Smalley RV
    J Biol Response Mod; 1983; 2(1):1-37. PubMed ID: 6196449
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
    Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
    Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP modulation of Fc receptor expression on a pre-B cell lymphoma.
    Burchiel SW; Warner NL
    J Immunol; 1980 Mar; 124(3):1016-21. PubMed ID: 6244345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon.
    Vialettes B; Baume D; Charpin C; De Maeyer-Guignard J; Vague P
    J Clin Lab Immunol; 1983 Jan; 10(1):35-40. PubMed ID: 6186814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse genes influence antiviral action of interferon in vivo.
    Dandoy F; De Maeyer-Guignard J; Bailey D; De Maeyer E
    Infect Immun; 1982 Oct; 38(1):89-93. PubMed ID: 6183213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection and allergy.
    Bristow VG
    Ann Allergy; 1980 Apr; 44(4):225-7. PubMed ID: 6154435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.